{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:56Z","timestamp":1772166356090,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-024-01494-1","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T07:02:55Z","timestamp":1724482975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic analysis of peritoneal washing cytology during interval debulking surgery in advanced ovarian cancer"],"prefix":"10.1186","volume":"17","author":[{"given":"Kazuki","family":"Takasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruko","family":"Hiraike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Sasajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Nagasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"1494_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","volume":"137","author":"KC Kurnit","year":"2021","unstructured":"Kurnit KC, Fleming GF, Lengyel E. Updates and new options in advanced epithelial ovarian cancer treatment. Obstet Gynecol. 2021;137:108\u201321.","journal-title":"Obstet Gynecol"},{"key":"1494_CR2","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.3802\/jgo.2019.30.e81","volume":"30","author":"Y Yoneoka","year":"2019","unstructured":"Yoneoka Y, Ishikawa M, Uehara T, Shimizu H, Uno M, Murakami T, et al. Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy? J Gynecol Oncol. 2019;30:e81.","journal-title":"J Gynecol Oncol"},{"key":"1494_CR3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1586\/era.11.24","volume":"11","author":"T Onda","year":"2011","unstructured":"Onda T, Yoshikawa H. Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions. Expert Rev Anticancer Ther. 2011;11:1053\u201367.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1494_CR4","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1002\/1097-0142(20011115)92:10<2585::AID-CNCR1611>3.0.CO;2-#","volume":"92","author":"W Kuhn","year":"2001","unstructured":"Kuhn W, Rutke S, Sp\u00e4the K, Schmalfeldt B, Florack G, von Hundelshausen B, et al. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer. 2001;92:2585\u201391.","journal-title":"Cancer"},{"key":"1494_CR5","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.3802\/jgo.2018.29.e70","volume":"29","author":"A Iura","year":"2018","unstructured":"Iura A, Takita M, Kawano A, Imai K, Konnai K, Onose R, et al. Negative peritoneal washing cytology during interval debulking surgery predicts overall survival after neoadjuvant chemotherapy for ovarian cancer. J Gynecol Oncol. 2018;29:e70.","journal-title":"J Gynecol Oncol"},{"key":"1494_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/jog.12616","volume":"41","author":"K Nagasaka","year":"2015","unstructured":"Nagasaka K, Kawana K, Tomio K, Tsuruga T, Mori-Uchino M, Miura S, et al. Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: a retrospective study. J Obstet Gynaecol Res. 2015;41:755\u201362.","journal-title":"J Obstet Gynaecol Res"},{"key":"1494_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ygyno.2021.12.016","volume":"164","author":"P Harter","year":"2022","unstructured":"Harter P, Mouret-Reynier MA, Pignata S, Cropet C, Gonz\u00e1lez-Mart\u00edn A, Bogner G, et al. Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1\/ENGOT-ov25 trial. Gynecol Oncol. 2022;164:254\u201364.","journal-title":"Gynecol Oncol"},{"key":"1494_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ygyno.2022.05.020","volume":"166","author":"MM Hardesty","year":"2022","unstructured":"Hardesty MM, Krivak TC, Wright GS, Hamilton E, Fleming EL, Belotte J, et al. OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab. Gynecol Oncol. 2022;166:219\u201329.","journal-title":"Gynecol Oncol"},{"key":"1494_CR9","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s11523-021-00841-2","volume":"16","author":"A Lee","year":"2021","unstructured":"Lee A. Niraparib: a review in first-line maintenance therapy in advanced ovarian cancer. Target Oncol. 2021;16:839\u201345.","journal-title":"Target Oncol"},{"key":"1494_CR10","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1158\/1078-0432.CCR-20-0054","volume":"26","author":"B You","year":"2020","unstructured":"You B, Robelin P, Tod M, Louvet C, Lotz JP, Abadie-Lacourtoisie S, et al. CA-125 ELIMination Rate Constant K (KELIM) is a marker of chemosensitivity in patients with ovarian cancer: results from the Phase II CHIVA trial. Clin Cancer Res. 2020;26:4625\u201332.","journal-title":"Clin Cancer Res"},{"key":"1494_CR11","doi-asserted-by":"crossref","unstructured":"Prat J, FIGO Committee on Gynecologic Oncology. FIGO\u2019s staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication. J Gynecol Oncol. 2015;26:87\u20139.","DOI":"10.3802\/jgo.2015.26.2.87"},{"key":"1494_CR12","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1200\/JCO.2016.68.1239","volume":"34","author":"LA Meyer","year":"2016","unstructured":"Meyer LA, Cronin AM, Sun CC, Bixel K, Bookman MA, Cristea MC, et al. Use and effectiveness of neoadjuvant chemotherapy for treatment of ovarian cancer. J Clin Oncol. 2016;34:3854\u201363.","journal-title":"J Clin Oncol"},{"key":"1494_CR13","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1002\/cam4.2377","volume":"8","author":"N Kojima","year":"2019","unstructured":"Kojima N, Yoshida H, Kuno I, Uehara T, Uno M, Ishikawa M, et al. Prognostic impact of intraoperative peritoneal cytologyin interval debulking surgery for pelvic high-grade serous carcinoma. Cancer Med. 2019;8:4598\u2013604.","journal-title":"Cancer Med"},{"key":"1494_CR14","first-page":"17","volume":"44","author":"TS Ghezelayagh","year":"2023","unstructured":"Ghezelayagh TS, Wu ES, Barber EL, Dao MD, Zsiros E, Urban RR, et al. Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study. Eur J Gynaecol Oncol. 2023;44:17\u201325.","journal-title":"Eur J Gynaecol Oncol"},{"key":"1494_CR15","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.3390\/ijms23136911","volume":"23","author":"CL Mao","year":"2022","unstructured":"Mao CL, Seow KM, Chen KH. The utilization of bevacizumab in patients with advanced ovarian cancer: a systematic review of the mechanisms and effects. Int J Mol Sci. 2022;23:6911.","journal-title":"Int J Mol Sci"},{"key":"1494_CR16","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","volume":"381","author":"I Ray-Coquard","year":"2019","unstructured":"Ray-Coquard I, Pautier P, Pignata S, P\u00e9rol D, Gonz\u00e1lez-Mart\u00edn A, Berger R, et al. Olaparib plus bevacizumab as first-line maintenance in ovarian cancer. N Engl J Med. 2019;381:2416\u201328.","journal-title":"N Engl J Med"},{"key":"1494_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s10147-023-02329-7","volume":"28","author":"S Nagao","year":"2023","unstructured":"Nagao S, Tamura J, Shibutani T, Miwa M, Kato T, Shikama A, et al. Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study. Int J Clin Oncol. 2023;28:804\u201315.","journal-title":"Int J Clin Oncol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01494-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01494-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01494-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T07:07:23Z","timestamp":1724483243000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01494-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01494-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3441238\/v1","asserted-by":"object"}]},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]},"assertion":[{"value":"13 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Teikyo University (approval number 13\u2013003-5). The requirement for informed consent was waived owing to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}